Drug Trial Radar · NCT03019627
An 8-week Study to Evaluate Safety and Efficacy of NGF Eye Drops Solution Versus Vehicle in Patients With Dry Eye
Last checked: Nov 20, 2026Latest source record: Feb 8, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
150
Actual
Start
Jan 20, 2017
Primary completion
Aug 31, 2017
Study completion Aug 31, 2017
Sponsor
- Lead sponsor
- Dompé Farmaceutici S.p.AIndustry
- Sponsor type
- Industry
- First posted
- Jan 12, 2017
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study was to assess the efficacy and safety of rhNGF when administered as eye drops to patients with dry eye The secondary objectives of this study were: * To assess change from baseline in Symptom Assessment In Dry Eye (SANDE) scores (without imputation), corneal and conjunctival staining according to National Eye Institute (NEI) scale, and in Tear Film Break-up Time (TFBUT) and Schirmer test I, following 4 and 8 weeks of treatment. * To assess change in levels of inflammatory biomarker matrix metallopeptidase 9 (MMP-9) in tears following 8 weeks of treatment. * To assess the incidence and frequency of treatment-emergent adverse events (TEAEs) following 8 weeks of treatment.
Conditions
- Dry Eye
Interventions
NGFDrug
Eye Drop 20 μg/mL
VehicleOther
Vehicle Eye Drop
Primary outcomes
What the sponsor says the trial is designed to measure.
- Symptom Assessment in Dry Eye (SANDE) ScoresTime frame: week 8
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Penn Dry Eye and Ocular Surface Center, University of Pennsylvania
Philadelphia, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.